What sector does Arbutus Biopharma Corp (ABUS) operate in?
Arbutus Biopharma Corp belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Arbutus Biopharma Corp (ABUS) current stock price?
As of the latest data, Arbutus Biopharma Corp stock price is $4.67, with a previous close of $4.80. Arbutus Biopharma Corp lost -$0.14 in the last trading session, representing a -2.81% loss.
What is Arbutus Biopharma Corp (ABUS) current market capitalization?
Arbutus Biopharma Corp market cap is approximately 921.51 million.
What is Arbutus Biopharma Corp (ABUS) Earnings Per Share (EPS)?
The trailing EPS is $0.83, and the forward EPS is -$0.12.
What is Arbutus Biopharma Corp (ABUS) Price-to-Earnings (P/E) ratio?
Arbutus Biopharma Corp current P/E ratio is 5.62.
What is Arbutus Biopharma Corp (ABUS) EBITDA?
Arbutus Biopharma Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 169.72 million.
Does Arbutus Biopharma Corp (ABUS) pay dividends?
No. Arbutus Biopharma Corp does not pay a dividend.
How did Arbutus Biopharma Corp (ABUS) perform in its most recent earnings report?
In the last report (March 31, 2026), Arbutus Biopharma Corp posted an EPS surprise of 2,480% and a revenue surprise of 11,599.93%.
When is Arbutus Biopharma Corp (ABUS) next earnings report?
Arbutus Biopharma Corp is expected to release its next earnings report on June 30, 2026.
What is Arbutus Biopharma Corp (ABUS) beta (volatility) score?
Arbutus Biopharma Corp has a beta of 0.618, indicating lower volatility than the overall market.